Skip to main content

Table 3 Hazard ratio (HR) for all-cause 30-day or 1-year mortality of SHR and ABG in the patients with diabetes

From: Prognostic significance of the stress hyperglycemia ratio and admission blood glucose in diabetic and nondiabetic patients with spontaneous intracerebral hemorrhage

Variables

30-day mortality

 

1-year mortality

Unadjusted model

 

Adjusted model c

 

Unadjusted model

 

Adjusted model d

HR(95% CI)

p value

p-trend

 

HR(95% CI)

p value

p-trend

 

HR(95% CI)

p value

p-trend

 

HR(95% CI)

p value

p-trend

SHR

               

Continuous variable

per unit

2.95 (1.82,4.77)

< 0.001

  

2.63 (1.50,4.60)

< 0.001

  

2.04 (1.34,3.10)

< 0.001

  

2.12 (1.33,3.39)

0.002

 

Quantile a

  

0.003

   

0.042

   

0.050

   

0.132

Q1 (n = 60)

Ref

       

Ref

      

Q2 (n = 62)

0.57 (0.21,1.56)

0.270

  

0.65 (0.23,1.87)

0.430

  

0.66 (0.33,1.31)

0.235

  

0.67 (0.33,1.39)

0.288

 

Q3 (n = 60)

0.79 (0.31,2.00)

0.621

  

0.58 (0.22,1.53)

0.268

  

0.94 (0.50,1.75)

0.837

  

0.69 (0.35,1.34)

0.273

 

Q4 (n = 61)

0.99 (0.41,2.37)

0.974

  

1.01 (0.41,2.52)

0.975

  

0.90 (0.48,1.70)

0.745

  

1.14 (0.58,2.25)

0.701

 

Q5 (n = 61)

2.27 (1.06,4.86)

0.034

  

1.59 (0.72,3.52)

0.254

  

1.53 (0.86,2.75)

0.150

  

1.26 (0.67,2.37)

0.469

 

ABG

               

Continuous variable

per unit

1.00 (1.00,1.01)

0.007

  

1.00 (0.99,1.01)

0.350

  

1.00 (0.99,1.01)

0.103

  

1.01 (0.99,1.01)

0.232

 

Quantile b

  

0.008

   

0.010

   

0.074

   

0.254

Q1 (n = 61)

Ref

       

Ref

      

Q2 (n = 62)

1.40 (0.56,3.47)

0.472

  

1.06 (0.41,2.74)

0.912

  

0.90 (0.47,1.73)

0.756

  

0.61 (0.30,1.23)

0.167

 

Q3 (n = 60)

1.03 (0.39,2.73)

0.959

  

0.86 (0.31,2.39)

0.779

  

1.08 (0.58,2.03)

0.802

  

1.22 (0.62,2.39)

0.563

 

Q4 (n = 60)

1.05 (0.39,2.79)

0.927

  

0.98 (0.36,2.67)

0.963

  

0.81 (0.41,1.60)

0.543

  

0.85 (0.42,1.72)

0.657

 

Q5 (n = 61)

2.72 (1.19,6.21)

0.018

  

2.38 (0.99,5.76)

0.054

  

1.63 (0.90,2.95)

0.104

  

2.01 (0.96,3.83)

0.234

 
  1. a SHR: Q1 (≤ 0.833), Q2 (0.833–0.981), Q3 (0.981–1.162), Q4 (1.162–1.409), Q5 (>1.409)
  2. b ABG: Q1 (≤ 119.6), Q2 (119.6–146), Q3 (146–179), Q4 (179-238.8), Q5 (>238.8)
  3. c Adjusted model was adjusted for the variables with a p value < 0.01 in the univariable Cox regression, including gender, age, mean arterial pressure, SpO2, neutrophil percentage, lymphocyte percentage, hemoglobin, and red blood cell distribution width
  4. d Adjusted model was adjusted for the variables with a p value < 0.01 in the univariable Cox regression, including gender, age, myocardial infarct, congestive heart failure, renal disease, mean arterial pressure, respiratory rate, SpO2, Glasgow Coma Scale, hemoglobin, red blood cell distribution width, serum sodium, creatinine, and blood urea nitrogen